ArticleOxford medical case reports2019

Extended treatment with MY-NEOVAX, personalized neoantigen-enhanced oncolytic viruses, for two end-stage cancer patients.

Michael Bouvet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.